Barclays Downgrades Gossamer Bio Inc. (GOSS) to Equalweight
Tweet Send to a Friend
(Updated - December 7, 2022 5:49 AM EST)
Barclays analyst Carter Gould downgraded Gossamer Bio Inc. (NASDAQ: GOSS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst Carter Gould downgraded Gossamer Bio Inc. (NASDAQ: GOSS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
